Skip to main content
Thorax logoLink to Thorax
. 1996 Jul;51(7):739–742. doi: 10.1136/thx.51.7.739

Cytokines in bronchoalveolar lavage fluid in patients with high altitude pulmonary oedema at moderate altitude in Japan.

K Kubo 1, M Hanaoka 1, S Yamaguchi 1, T Hayano 1, M Hayasaka 1, T Koizumi 1, K Fujimoto 1, T Kobayashi 1, T Honda 1
PMCID: PMC472499  PMID: 8882083

Abstract

BACKGROUND: The precise mechanism of high altitude pulmonary oedema (HAPE) remains unclear. The purpose of this study was to evaluate the role of cytokines and P-selectin in the development of HAPE which occurred at moderate altitude in Japan. METHODS: The following cellular and biochemical markers and chemotactic cytokines were measured in the bronchoalveolar (BAL) fluid from four patients with HAPE at 2857-3180 m in the Japanese Alps: total proteins, albumin, lactate dehydrogenase (LDH), and interleukin (IL)-1 alpha, IL-1 beta, IL-1 receptor antagonist (ra), IL-6, IL-8, IL-10, tumour necrosis factor (TNF)-alpha, and the soluble form of P-selectin. RESULTS: At admission there were significant increases in the levels of total cells, especially macrophages and neutrophils, total protein, albumin and LDH when compared with 13 healthy individuals. Furthermore, the levels of IL-1 beta, IL-6, IL-8, and TNF-alpha were also considerably increased but returned quickly to the normal ranges or were not detected after recovery. The levels of IL-1 alpha, IL-10, and P-selectin did not change. CONCLUSIONS: These results suggest that an inflammatory process almost identical with acute respiratory distress syndrome (ARDS) may occur in HAPE, but that these changes are transient and are not associated with any increase in P-selectin levels in the BAL fluid.

Full text

PDF
739

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bärtsch P., Maggiorini M., Ritter M., Noti C., Vock P., Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991 Oct 31;325(18):1284–1289. doi: 10.1056/NEJM199110313251805. [DOI] [PubMed] [Google Scholar]
  2. Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood. 1994 Oct 1;84(7):2068–2101. [PubMed] [Google Scholar]
  3. Karakurum M., Shreeniwas R., Chen J., Pinsky D., Yan S. D., Anderson M., Sunouchi K., Major J., Hamilton T., Kuwabara K. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest. 1994 Apr;93(4):1564–1570. doi: 10.1172/JCI117135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kawashima A., Kubo K., Kobayashi T., Sekiguchi M. Hemodynamic responses to acute hypoxia, hypobaria, and exercise in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol (1985) 1989 Nov;67(5):1982–1989. doi: 10.1152/jappl.1989.67.5.1982. [DOI] [PubMed] [Google Scholar]
  5. Kobayashi T., Koyama S., Kubo K., Fukushima M., Kusama S. Clinical features of patients with high-altitude pulmonary edema in Japan. Chest. 1987 Nov;92(5):814–821. doi: 10.1378/chest.92.5.814. [DOI] [PubMed] [Google Scholar]
  6. Kollef M. H., Schuster D. P. The acute respiratory distress syndrome. N Engl J Med. 1995 Jan 5;332(1):27–37. doi: 10.1056/NEJM199501053320106. [DOI] [PubMed] [Google Scholar]
  7. Matsuzawa Y., Fujimoto K., Kobayashi T., Namushi N. R., Harada K., Kohno H., Fukushima M., Kusama S. Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol (1985) 1989 Mar;66(3):1152–1157. doi: 10.1152/jappl.1989.66.3.1152. [DOI] [PubMed] [Google Scholar]
  8. Rivier A., Pène J., Chanez P., Anselme F., Caillaud C., Préfaut C., Godard P., Bousquet J. Release of cytokines by blood monocytes during strenuous exercise. Int J Sports Med. 1994 May;15(4):192–198. doi: 10.1055/s-2007-1021046. [DOI] [PubMed] [Google Scholar]
  9. Sakamaki F., Ishizaka A., Handa M., Fujishima S., Urano T., Sayama K., Nakamura H., Kanazawa M., Kawashiro T., Katayama M. Soluble form of P-selectin in plasma is elevated in acute lung injury. Am J Respir Crit Care Med. 1995 Jun;151(6):1821–1826. doi: 10.1164/ajrccm.151.6.7539327. [DOI] [PubMed] [Google Scholar]
  10. Schoene R. B., Swenson E. R., Pizzo C. J., Hackett P. H., Roach R. C., Mills W. J., Jr, Henderson W. R., Jr, Martin T. R. The lung at high altitude: bronchoalveolar lavage in acute mountain sickness and pulmonary edema. J Appl Physiol (1985) 1988 Jun;64(6):2605–2613. doi: 10.1152/jappl.1988.64.6.2605. [DOI] [PubMed] [Google Scholar]
  11. St John R. C., Dorinsky P. M. Immunologic therapy for ARDS, septic shock, and multiple-organ failure. Chest. 1993 Mar;103(3):932–943. doi: 10.1378/chest.103.3.932. [DOI] [PubMed] [Google Scholar]
  12. Suter P. M., Suter S., Girardin E., Roux-Lombard P., Grau G. E., Dayer J. M. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992 May;145(5):1016–1022. doi: 10.1164/ajrccm/145.5.1016. [DOI] [PubMed] [Google Scholar]
  13. Windsor A. C., Mullen P. G., Fowler A. A., Sugerman H. J. Role of the neutrophil in adult respiratory distress syndrome. Br J Surg. 1993 Jan;80(1):10–17. doi: 10.1002/bjs.1800800106. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES